It looks like Clarus Ventures is planning to reload with investment capital for life science companies.
The Boston- and San Francisco-based venture firm revealed in a SEC filing it’s looking to raise up to $375 million for a third fund.
{iframe}http://medcitynews.com/2014/02/clarus-ventures-375-million-third-fund/{/iframe}